Mesa Laboratories is a scientific & technical instruments business based in the US. Mesa Laboratories shares (MLAB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $119.06 – an increase of 2.21% over the previous week. Mesa Laboratories employs 736 staff and has a trailing 12-month revenue of around $237.7 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $119.06 |
|---|---|
| 52-week range | $83.37 - $154.94 |
| 50-day moving average | $122.86 |
| 200-day moving average | $125.57 |
| Wall St. target price | $141.67 |
| PE ratio | N/A |
| Dividend yield | $0.64 (0.54%) |
| Earnings per share (TTM) | $-46.31 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $119.06 from 2025-05-02
| 1 week (2025-04-25) | 2.21% |
|---|---|
| 1 month (2025-04-04) | 10.24% |
| 3 months (2025-02-04) | -13.27% |
| 6 months (2024-11-04) | 0.51% |
| 1 year (2024-05-03) | 3.08% |
|---|---|
| 2 years (2023-05-03) | -28.57% |
| 3 years (2022-05-03) | 215.2975 |
| 5 years (2020-05-04) | 223.0716 |
Valuing Mesa Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mesa Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mesa Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $43.9 million.
The EBITDA is a measure of a Mesa Laboratories's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $237.7 million |
|---|---|
| Operating margin TTM | 9.2% |
| Gross profit TTM | $151.5 million |
| Return on assets TTM | 2.18% |
| Return on equity TTM | -89.38% |
| Profit margin | -104.92% |
| Book value | $28.57 |
| Market Capitalization | $646.9 million |
TTM: trailing 12 months
Dividend payout ratio: 28.3% of net profits
Recently Mesa Laboratories has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Mesa Laboratories shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Mesa Laboratories's case, that would currently equate to about $0.64 per share.
While Mesa Laboratories's payout ratio might seem fairly standard, it's worth remembering that Mesa Laboratories may be investing much of the rest of its net profits in future growth.
Mesa Laboratories's most recent dividend payout was on 15 June 2025. The latest dividend was paid out to all shareholders who bought their shares by 29 May 2025 (the "ex-dividend date").
Over the last 12 months, Mesa Laboratories's shares have ranged in value from as little as $83.3686 up to $154.9367. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mesa Laboratories's is 0.923. This would suggest that Mesa Laboratories's shares are less volatile than average (for this exchange).
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .